SLC5A2 and diabetes mellitus: Indeed, experimental studies evidenced that SGLT2i reduced the infarct size in different animal models with and without diabetes [18, 19], an effect also observed in Sglt2 knockout mice, suggesting independence from SGLT2 expression [20].